C3/C5 Depleted Serum

$120.00

C3/C5-Depleted Serum is normal human serum in which C3 and C5 have been removed by immunoaffinity chromatography.

Brand

SKU: A342C Category:

Description

General Description

C3/C5-Depleted Serum is normal human serum in which C3 and C5 have been removed by immunoaffinity chromatography. The product is tested for the absence of C3 and C5 activity by testing classical and alternative pathway function and for the absence of C3 and C5 proteins by double immunodiffusion. The C3/C5-depleted serum is certified to exhibit less than 5% classical pathway and alternative pathway activities. Functional classical and alternative pathways can be reconstituted by addition of purified C3 protein (1.3 mg/mL) and C5 protein (75 ug/mL) indicating that all other complement components necessary for classical and alternative pathway activation are present. After reconstitution with C3 (1.3 mg C3/mL) and C5 (0.75mg/mL), the C3/C5-Depleted Serum is certified to possess a functional classical and alternative pathway for complement activation (Morgan, B.P. (2000); Dodds, A.W. and Sim, R.B. (1997)). Although a functional lectin pathway should also be reconstituted by the addition of similar concentrations of C3 and C5, the function of this pathway is not tested.

Physical Characteristics & Structure

C3/C5-Depleted Serum is supplied as a clear, straw-colored liquid containing all proteins of normal human serum except C3 and C5.

Specifications

Sizes Available:                0.5 mL/vial
Concentration:                 >50 mg protein/mL (see Certificate of Analysis for actual conc.)
Form:                                 Frozen liquid
Activity:                             >80% versus NHS standard when reconstituted with C3 and C5.
Buffer:                               10 mM sodium phosphate, 145 mM NaCl, pH 7.3
Preservative:                    None, 0.22 µm filtered
Storage:                            -70o C or below. Minimize freeze/thaw cycles.
Source:                              Normal human serum (shown by certified tests to be negative for HBsAg and for antibodies to HCV, HIV-1 and HIV-II).
Precautions:                     Use normal precautions for handling human blood products.
Origin:                                Manufactured in the USA.

Additional Information

Function

C3/C5-Depleted Serum is tested for classical pathway activity by hemolytic assays using antibody-sensitized sheep erythrocytes (CompTech #B200) and for alternative pathway function using rabbit erythrocytes (CompTech #B300). The depleted serum is reconstituted with 1.3 mg/mL C3 (CompTech #A113c) and 75 µg/mL C5 (CompTech #A120) and retested to verify that functional classical and alternative pathways are restored. The Certificate of Analysis provided with each lot gives a description of the assays and specific titers for the depleted and reconstituted sera compared to normal human serum.

Assays

The unit of classical pathway activity is the CH50 and for the alternative pathway it is the AP50. A CH50 unit is the amount of complement needed to lyse 50% of 1 x 108 EA cells (antibody-sensitized sheep erythrocytes (CompTech #B200)) when that amount of serum is incubated with the EA in GVB++ (CompTech #B100) in a total volume of 1.5 mL for 60 min at 37o C. See the Certificate of Analysis for lot specific values. An AP50 is defined as the amount of complement yielding 50% lysis of 1.5 x 107 rabbit erythrocytes (Er, CompTech #B300) when incubated for 30 min at 37o C in a total reaction volume of 100 µL of GVBo containing a final MgEGTA concentration of 5 mM. Lectin pathway activity of C3/C5-Depleted Serum is not tested, but it would be expected to be inactive due to the absence of C3 and C5.

Applications

C3/C5-Depleted Serum is used as a source of serum with minimal ability to activate any of the three pathways of complement. However, C1 can be activated as well as the lectin pathway complexes of the lectins and MASPs. These complexes will then activate C2 that will attach to C4 generating the convertase C4b,C2a which is able to activate C5 (Rawal, N. & Pang burn, M.K. 2003) via a weak C3 by-pass mechanism. However, complement activation via the C3 by-pass mechanism is impossible because the C3/C5-Dpl has no C5.

What Makes Us Unique?

GSA MEDICAL portfolio offers a comprehensive workflow for your lab needs with wide range of tools.

As of 2020, GSA MEDICAL INC. started providing premier Manufacturing services to the diagnostic industry. GSA MEDICAL can effectively analyze the feasibility of reagents for use in rapid immunoassays. This process offers a quick glance as to the potential a reagent or concept may have and can result in saving considerable time and money for GSAMEDICAL’s clients.

We provide strong personal support, technical competence, and experience to ensure customer expectations will be met or exceeded.

Shop Products